Proton pump inhibitors (PPIs) are a class of medications used to treat conditions involving excess stomach acid, such as ...

Although proton pump inhibitors may reduce heartburn and gastrointestinal bleeding in hospital patients, the therapy may also raise their mortality risk, according to a recent study published in the ...

Dr. Keith Roach is a physician at Weill Cornell Medical College and New York Presbyterian Hospital. He writes an educational column on infectious diseases, public health and sports medicine. DEAR DR.

Please provide your email address to receive an email when new articles are posted on . Although proton pump inhibitors were linked with an increased risk for infection and decompensation in patients ...

Proton pump inhibitors have an adverse effect on vascular functions and increase heart attack risk, according to a study published in PLOS One. Using data mining, researchers queried over 16 million ...

There could be an association between the use of proton pump inhibitors and dementia in the elderly, according to a recent German study. 1. The study authors examined claims data from a German health ...

Controversy regarding the purported link between the use of proton pump inhibitors (PPIs) or histamine H2 receptor antagonists (H2RAs) and risk for dementia continues. Adding to the "no link" column ...

SAN DIEGO—Renal transplant recipients who use of proton pump inhibitors (PPIs) and mycophenolate mofetil (MMF) in the first year after transplantation may be at increased risk for allograft acute ...

Please provide your email address to receive an email when new articles are posted on . Findings showed use was associated with fatigue and lower health-related quality of life. The associations were ...

A study published in Current Opinions Gastroenterology examined the recent research on adverse effects attributed to proton pump inhibitors, Medscape reports. 1. Several studies have attributed ...